MAIA Biotechnology, Inc.: shareholders and insiders

MAIAAMEXHealthcare · Pharmaceutical Preparations

Price

$1.11

November 20, 2026Market cap $67M

What Ploutos Investor adds for MAIA Biotechnology

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 17, 2026, from their own Form 4 filings.

25 Form 4s

Bought on the market

$1.2M

7 people

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $756.7K by 4 people·no sales

  • 2025: bought $412.3K by 5 people, no sales
  • 2026: bought $756.7K by 4 people, no sales
  • Nov 16, 2026Stan SmithDirector
    Kind
  • Nov 16, 2026Vlad VitocChief Executive Officer
    Kind
  • Nov 13, 2026Stan SmithDirector
    Kind
  • Nov 13, 2026Vlad VitocChief Executive Officer
    Kind
  • Sep 14, 2026Vlad VitocChief Executive Officer
    Kind
  • Sep 10, 2026Ramiro GuerreroDirector
    Kind
  • Aug 28, 2026Ramiro GuerreroDirector
    Kind
  • Aug 27, 2026Ramiro GuerreroDirector
    Kind
  • Aug 26, 2026Ramiro GuerreroDirector
    Kind
  • Aug 24, 2026Ramiro GuerreroDirector
    Kind
  • Aug 20, 2026Ramiro GuerreroDirector
    Kind
  • Jun 1, 2026Vlad VitocChief Executive Officer
    Kind
  • Jun 1, 2026Stan SmithDirector
    Kind
  • Jun 1, 2026Sergei GryaznovChief Scientific Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 1, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by MAIA's officers and directors from 2022 up to November 21, 2025, 4 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%1 On a 13DAug 14, 2026 Latest filing
  • FGMK Business Holdings, LLCwith 1 more person
    Share of class9.99%
  • Vlad Vitoc
    Share of class9.66%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Vlad Vitoc9.7%From the filing of Dec 4, 2025

    The Reporting Person acquired the Common Stock reported in this Statement for investment purposes. The Reporting Person may in the future acquire additional Common Stock or dispose of some or all of the Common Stock held by the Reporting Person in open-market transactions or privately negotiated transactions, on such terms and at such times as the Reporting Person may deem advisable. The Reporting Person may engage in short selling or hedging or similar transactions with respect to the Common Stock, on such terms and at such times as the Reporting Person may deem advisable, subject to applicable law. The Reporting Person has no present plan or proposal that would result in any of the…

    From the filing of Dec 4, 2025
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Solas Capital Management, LLC4.90%Aug 14, 202613G/A
  • Sergei M. Gryaznov4.08%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+812%
  • Renaissance Technologies
    In the quarter-4.0%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 4.16% of its shares outstanding were held short, -6.2% since the report before.

Shares held short
2.52M
4.16%
Since the report before2.69M on Sep 30, 2026
-6.2%
5.8
435.4K
More days to cover thanof 4,578 US-listed companies with enough volume
69%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 302.0K
  • Nov 15, 2023: Shares held short 272.9K
  • Nov 30, 2023: Shares held short 178.9K
  • Dec 15, 2023: Shares held short 43.1K
  • Dec 29, 2023: Shares held short 94.4K
  • Jan 12, 2024: Shares held short 268.4K
  • Jan 31, 2024: Shares held short 387.1K
  • Feb 15, 2024: Shares held short 434.5K
  • Feb 29, 2024: Shares held short 388.8K
  • Mar 15, 2024: Shares held short 508.5K
  • Mar 28, 2024: Shares held short 845.1K
  • Apr 15, 2024: Shares held short 785.2K
  • Apr 30, 2024: Shares held short 1.01M
  • May 15, 2024: Shares held short 1.22M
  • May 31, 2024: Shares held short 623.7K
  • Jun 14, 2024: Shares held short 590.0K
  • Jun 28, 2024: Shares held short 673.7K
  • Jul 15, 2024: Shares held short 675.5K
  • Jul 31, 2024: Shares held short 777.3K
  • Aug 15, 2024: Shares held short 669.3K
  • Aug 30, 2024: Shares held short 633.2K
  • Sep 13, 2024: Shares held short 626.4K
  • Sep 30, 2024: Shares held short 693.5K
  • Oct 15, 2024: Shares held short 696.4K
  • Oct 31, 2024: Shares held short 662.4K
  • Nov 15, 2024: Shares held short 726.3K
  • Nov 29, 2024: Shares held short 673.0K
  • Dec 13, 2024: Shares held short 647.0K
  • Dec 31, 2024: Shares held short 682.4K
  • Jan 15, 2025: Shares held short 636.8K
  • Jan 31, 2025: Shares held short 674.3K
  • Feb 14, 2025: Shares held short 986.7K
  • Feb 28, 2025: Shares held short 950.6K
  • Mar 14, 2025: Shares held short 708.7K
  • Mar 31, 2025: Shares held short 737.4K
  • Apr 15, 2025: Shares held short 622.5K
  • Apr 30, 2025: Shares held short 576.6K
  • May 15, 2025: Shares held short 561.6K
  • May 30, 2025: Shares held short 360.5K
  • Jun 13, 2025: Shares held short 394.1K
  • Jun 30, 2025: Shares held short 602.0K
  • Jul 15, 2025: Shares held short 406.9K
  • Jul 31, 2025: Shares held short 713.1K
  • Aug 15, 2025: Shares held short 626.6K
  • Aug 29, 2025: Shares held short 653.0K
  • Sep 15, 2025: Shares held short 846.5K
  • Sep 30, 2025: Shares held short 714.7K
  • Oct 15, 2025: Shares held short 591.3K
  • Oct 31, 2025: Shares held short 1.00M
  • Nov 14, 2025: Shares held short 949.5K
  • Nov 28, 2025: Shares held short 688.0K
  • Dec 15, 2025: Shares held short 1.69M
  • Dec 31, 2025: Shares held short 1.65M
  • Jan 15, 2026: Shares held short 1.63M
  • Jan 30, 2026: Shares held short 1.98M
  • Feb 13, 2026: Shares held short 2.09M
  • Feb 27, 2026: Shares held short 2.46M
  • Mar 13, 2026: Shares held short 1.82M
  • Mar 31, 2026: Shares held short 2.30M
  • Apr 15, 2026: Shares held short 2.83M
  • Apr 30, 2026: Shares held short 3.17M
  • May 15, 2026: Shares held short 2.82M
  • May 29, 2026: Shares held short 2.95M
  • Jun 15, 2026: Shares held short 3.18M
  • Jun 30, 2026: Shares held short 3.41M
  • Jul 15, 2026: Shares held short 2.92M
  • Jul 31, 2026: Shares held short 3.06M
  • Aug 14, 2026: Shares held short 2.75M
  • Aug 31, 2026: Shares held short 2.35M
  • Sep 15, 2026: Shares held short 2.10M
  • Sep 30, 2026: Shares held short 2.69M
  • Oct 15, 2026: Shares held short 2.52M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading51.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 51.9% of the shares in the reported trades were short sales, against 50.6% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
51.9%
The 14 beforeOct 14, 2026 – Nov 2, 2026
50.6%
Change
+1.3 pts
Short sales a dayon average, of 352.4K shares
183.1K
More than atof 3,666 US-listed companies, same days
55%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 50.2%
  • Oct 15, 2026: Short sales 49.4%
  • Oct 16, 2026: Short sales 56.8%
  • Oct 19, 2026: Short sales 47.2%
  • Oct 20, 2026: Short sales 79.2%
  • Oct 21, 2026: Short sales 59.7%
  • Oct 22, 2026: Short sales 55.9%
  • Oct 23, 2026: Short sales 53.7%
  • Oct 26, 2026: Short sales 36.6%
  • Oct 27, 2026: Short sales 51.5%
  • Oct 28, 2026: Short sales 59.9%
  • Oct 29, 2026: Short sales 65.4%
  • Oct 30, 2026: Short sales 25.3%
  • Nov 2, 2026: Short sales 57.2%
  • Nov 3, 2026: Short sales 47.5%
  • Nov 4, 2026: Short sales 76.6%
  • Nov 5, 2026: Short sales 39.8%
  • Nov 6, 2026: Short sales 44%
  • Nov 9, 2026: Short sales 60%
  • Nov 10, 2026: Short sales 49.2%
  • Nov 11, 2026: Short sales 44.8%
  • Nov 12, 2026: Short sales 47%
  • Nov 13, 2026: Short sales 42.5%
  • Nov 16, 2026: Short sales 60%
  • Nov 17, 2026: Short sales 59.7%
  • Nov 18, 2026: Short sales 47.2%
  • Nov 19, 2026: Short sales 54.7%
  • Nov 20, 2026: Short sales 38.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

5.65M Insiders' shares9.31% Of the company
  • Stan SmithDirector
    Directly113.7K
  • Vlad VitocChief Executive Officer
    Directly1.36M
  • Ngar Yee LouieDirector
    Directly1.25M
  • Ramiro GuerreroDirector
    Directly773.3K
  • Cristian LuputDirector
    Directly437.6K
  • Steven M ChaoukiDirector
    Directly151.9K
  • Sergei GryaznovChief Scientific Officer
    Directly46.5K

A lower bound: it counts only the 7 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

3 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

36 Managers, Q2 2026$19M Value of their positions
  • Q3 2025: Managers 19
  • Q4 2025: Managers 26
  • Q1 2026: Managers 33
  • Q2 2026: Managers 36

Institutional investors by quarter

The fund managers holding MAIA, quarter by quarter, from Q3 2022 to Q2 2025, 12 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 36 managers held 13.52M shares, worth $19M. During the quarter 13 opened a position, 10 closed one, 8 added and 3 trimmed.

The largest holders, Q2 2026

  • Solas Capital Management
    In the quarter-29%
  • Alyeska Investment Group
    In the quarter
  • Vanguard Capital Management
    In the quarter+16%
  • 683 Capital Management
    In the quarter
  • Centric Wealth Management
    In the quarter
  • Cable Car Capital
    In the quarter-21%
  • Geode Capital Management
    In the quarter+40%
  • Bleichroeder
    In the quarter
  • Renaissance Technologies
    In the quarter
  • BlackRock
    In the quarter+215%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do MAIA Biotechnology's filings show?

Who buys and sells is one part of MAIA Biotechnology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MAIA's shareholders

Didn't find what you were looking for?

Ask us
Have MAIA's insiders bought or sold?

From Jun 1, 2026 to Nov 17, 2026 MAIA Biotechnology's insiders bought $756.1K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold MAIA?

3 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $500.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.